Medtronic
Medtronic Medtronic
Medtronic
Medtronic
Medtronic
Medtronic
Physician Information > Cardiovascular Surgery >
Resting Heart® System
 
 
 
 
 
 
 
Medtronic Indications, contraindications, warnings, precautions, and adverse events
 
 
 
Medtronic
Medtronic

Medtronic® Resting Heart® System offers a New Approach to Reducing Cardiac Surgery Morbidity


TEAMWORK



TECHNIQUE



TECHNOLOGY

  • Using closed-to-air systems to eliminate an air-blood interface that can activate blood.1,2,3
  • Minimizing hemodilution and circuit surface area by using low-prime circuits, retrograde autologous priming (or RAP) techniques, and strategies for fluid management43,44,45,46 to reduce bleeding with higher postoperative hematocrits.
  • Coating blood-contacting surfaces with Carmeda®* BioActive Surface (a heparin bioactive surface) which mimics critical characteristics of vascular endothelium to provide thromboresistance and biocompatibility.
    24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40
  • Sequestering shed and suctioned blood to prevent the development of systemic inflammatory response and keep air, lipids and particulate emboli from being introduced into the patient’s circulation.1,2,3,4
  • Optimizing anticoagulation using a hemostasis management system that identifies patient specific heparin and protamine requirements.1,2,3,42
  • Realize potential savings from a reduction in blood product usage.56

* Carmeda® BioActive Surface. Manufactured under license from Carmeda
AB, Sweden. Carmeda is a registered trademark of Carmeda AB.

 



Home About Medtronic